Latest Regulatory News

Betashares Mrtn Currie Eqy Inc Fund (EINC) units have been suspended from trading on the ASX as of 22 January 2025, following a prior announcement in December 2024.

Australian Pacific Coal Limited has responded to ASX inquiries regarding recent unusual trading activity, confirming no undisclosed information exists and affirming compliance with listing rules.

The ASX has released its latest list of entities suspended for over three months, outlining critical deadlines for outstanding report lodgements and potential removal from the official list.

Vinyl Group Ltd has updated the timeline for its Entitlements Offer, delaying the final allotment of underwritten shortfall securities to January 28, 2025, with shares to be listed the following day.

BPH Energy Limited's December 2024 quarterly report reveals strategic capital placements and investments in hydrogen and medical technology, alongside ongoing regulatory challenges with the PEP-11 permit.

Latin Resources Limited confirms the legal effectiveness of its acquisition by Pilbara Minerals Limited via share and option schemes, setting the stage for key trading milestones.

Patagonia Lithium Ltd has announced a maiden JORC Inferred Mineral Resource Estimate of 3.8 million tonnes of Lithium Carbonate Equivalent at its Formentera Lithium Brine Project in Argentina, highlighting significant potential for resource upgrades through ongoing drilling and advanced extraction technology.

ADX Energy has accepted the award of a significant gas exploration permit offshore Italy’s Sicily Channel, positioning itself to tap into a highly prospective area with proven gas presence and favorable fiscal terms.

Star Minerals secures shareholder approval for its Cobra Uranium Project in Namibia and prepares for maiden drilling, while progressing gold exploration in Western Australia amid a modest capital raise.

Kula Gold Limited has secured a 75% stake in Malawi’s Wozi Niobium Project, revealing promising historical niobium and tantalum mineralisation and setting sights on a maiden drilling program in Q2 2025.

Range International Limited delivered a standout Q4 2024 with record sales revenue from its Re>Pal Indonesia operations, alongside improved margins and positive cash flow, signaling a robust turnaround.

Island Pharmaceuticals has enrolled all subjects in the Phase 2b arm of its ISLA-101 dengue fever clinical trial, advancing its antiviral drug development with key results expected in 2025.